Search Results - "Kunimoto, Dennis Y."

Refine Results
  1. 1

    Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine by Gupta, Nancy, Garg, Saurabh, Vedi, Satish, Kunimoto, Dennis Y, Kumar, Rakesh, Agrawal, Babita

    Published in Frontiers in immunology (16-10-2018)
    “…Tuberculosis (TB), an infectious disease caused by ( ), kills 5,000 people per day globally. Rapid development and spread of various multi drug-resistant…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Harnessing Innate Immunity to Treat Mycobacterium tuberculosis Infections: Heat-Killed Caulobacter crescentus as a Novel Biotherapeutic by Gupta, Nancy, Vedi, Satish, Garg, Saurabh, Loo, Eric, Li, Jie, Kunimoto, Dennis Y, Kumar, Rakesh, Agrawal, Babita

    Published in Cells (Basel, Switzerland) (09-02-2023)
    “…Tuberculosis, caused by ( ), is a serious and devastating infectious disease worldwide. Approximately a quarter of the world population harbors latent…”
    Get full text
    Journal Article
  4. 4

    Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis : Routes of immunization and TLR agonists critically impact vaccine’s efficacy by Gupta, Nancy, Vedi, Satish, Kunimoto, Dennis Y, Agrawal, Babita, Kumar, Rakesh

    Published in Vaccine (04-11-2016)
    “…Highlights • Novel subunit vaccine for Mtb by using simple lipid (palmitic acid) modified peptides from ESAT-6 protein. • Lipopeptides induce significant…”
    Get full text
    Journal Article
  5. 5

    Investigation of C-5 alkynyl (alkynyloxy or hydroxymethyl) and/or N-3 propynyl substituted pyrimidine nucleoside analogs as a new class of antimicrobial agents by Garg, Saurabh, Shakya, Neeraj, Srivastav, Naveen C., Agrawal, Babita, Kunimoto, Dennis Y., Kumar, Rakesh

    Published in Bioorganic & medicinal chemistry (01-11-2016)
    “…[Display omitted] The resurgence of mycobacterial infections and the emergence of drug-resistant strains urgently require a new class of agents that are…”
    Get full text
    Journal Article
  6. 6

    3′-Bromo Analogues of Pyrimidine Nucleosides as a New Class of Potent Inhibitors of Mycobacterium tuberculosis by Shakya, Neeraj, Srivastav, Naveen C, Desroches, Nancy, Agrawal, Babita, Kunimoto, Dennis Y, Kumar, Rakesh

    Published in Journal of medicinal chemistry (27-05-2010)
    “…Tuberculosis (TB) is a major health problem worldwide. We herein report a new class of pyrimidine nucleosides as potent inhibitors of Mycobacterium…”
    Get full text
    Journal Article
  7. 7

    Inhibition of Mycobacterial Replication by Pyrimidines Possessing Various C-5 Functionalities and Related 2′-Deoxynucleoside Analogues Using in Vitro and in Vivo Models by Srivastav, Naveen C, Rai, Dinesh, Tse, Christopher, Agrawal, B, Kunimoto, Dennis Y, Kumar, Rakesh

    Published in Journal of medicinal chemistry (26-08-2010)
    “…Tuberculosis (TB) has become an increasing problem since the emergence of human immunodeficiency virus and increasing appearance of drug-resistant strains…”
    Get full text
    Journal Article
  8. 8

    Synthesis and in vitro anti-mycobacterial activity of 5-substituted pyrimidine nucleosides by Johar, Monika, Manning, Tracey, Kunimoto, Dennis Y., Kumar, Rakesh

    Published in Bioorganic & medicinal chemistry (15-12-2005)
    “…Various 5-substituted unnatural pyrimidine nucleosides were synthesized and investigated as potential inhibitors of mycobacterial growth as anti-tuberculosis…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by Novel Dideoxy Nucleosides by Rai, Dinesh, Johar, Monika, Srivastav, Naveen C, Manning, Tracey, Agrawal, B, Kunimoto, Dennis Y, Kumar, Rakesh

    Published in Journal of medicinal chemistry (20-09-2007)
    “…The prevalence of tuberculosis (TB) and mutidrug-resistant tuberculosis (MDR-TB) has been increasing, leading to serious infections, high mortality, and a…”
    Get full text
    Journal Article
  12. 12

    Studies on acyclic pyrimidines as inhibitors of mycobacteria by Srivastav, Naveen C., Manning, Tracey, Kunimoto, Dennis Y., Kumar, Rakesh

    Published in Bioorganic & medicinal chemistry (01-03-2007)
    “…In vitro anti-mycobacterial activities of several 5-substituted acyclic pyrimidine nucleosides containing 1-(2-hydroxyethoxy)methyl and…”
    Get full text
    Journal Article
  13. 13

    Antimycobacterial activities of 5-alkyl (or halo)-3′-substituted pyrimidine nucleoside analogs by Srivastav, Naveen C., Shakya, Neeraj, Bhavanam, Sudha, Agrawal, Amogh, Tse, Chris, Desroches, Nancy, Kunimoto, Dennis Y., Kumar, Rakesh

    Published in Bioorganic & medicinal chemistry letters (15-01-2012)
    “…Several 5-alkyl (or halo)-3′-azido (amino or halo) analogs of pyrimidine nucleosides have been synthesized and evaluated against Mycobacterium bovis,…”
    Get full text
    Journal Article
  14. 14

    Design and Studies of Novel 5-Substituted Alkynylpyrimidine Nucleosides as Potent Inhibitors of Mycobacteria by Rai, Dinesh, Johar, Monika, Manning, Tracey, Agrawal, B, Kunimoto, Dennis Y, Kumar, Rakesh

    Published in Journal of medicinal chemistry (03-11-2005)
    “…We herein report a new category of 5-substituted pyrimidine nucleosides as potent inhibitors of mycobacteria. A series of 5-alkynyl derivatives of…”
    Get full text
    Journal Article
  15. 15

    Changing epidemiology of tuberculosis detected by an 8-year retrospective laboratory study in a tertiary teaching hospital in central Saudi Arabia by Somily, Ali M, Naeem, Tahir, Habib, Hanan A, Sarwar, Mohammed S, Kunimoto, Dennis Y, Kambal, Abdelmageed M

    Published in Saudi medical journal (01-07-2014)
    “…To study the laboratory diagnosis of tuberculosis (TB), and relate the findings to its epidemiology in Central Saudi Arabia. This retrospective study was…”
    Get more information
    Journal Article
  16. 16

    In vitro anti-mycobacterial activities of various 2'-deoxyuridine, 2'-arabinouridine and 2'-arabinofluoro-2'-deoxyuridine analogues: synthesis and biological studies by Srivastav, Naveen C, Manning, Tracey, Kunimoto, Dennis Y, Kumar, Rakesh

    “…M. tuberculosis, M. bovis and M. avium infections cause the most important mycobacterioses leading to increased mortality in patients with AIDS. Various…”
    Get more information
    Journal Article
  17. 17

    Transplantation in the face of severe donor sepsis: pushing the boundaries? by Pauly, Robert P, Rayner, David, Murray, Allan G, Gilmour, Susan M, Kunimoto, Dennis Y

    Published in American journal of kidney diseases (01-10-2004)
    “…Most current transplantation guidelines suggest that bacteremia or bacterial sepsis precludes organ donation. However, various investigators report good…”
    Get full text
    Journal Article
  18. 18

    IS1626, a new IS900-related Mycobacterium avium insertion sequence by Puyang, Xiaoling, Lee, Karen, Pawlichuk, Corey, Kunimoto, Dennis Y

    “…Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada T6G 2H7 1 Author for correspondence: Dennis Y. Kunimoto. Tel: +1 780…”
    Get full text
    Journal Article
  19. 19

    Harnessing Innate Immunity to Treat IMycobacterium tuberculosis/I Infections: Heat-Killed ICaulobacter crescentus/I as a Novel Biotherapeutic by Gupta, Nancy, Vedi, Satish, Garg, Saurabh, Loo, Eric, Li, Jie, Kunimoto, Dennis Y, Kumar, Rakesh, Agrawal, Babita

    Published in Cells (Basel, Switzerland) (01-02-2023)
    “…Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), is a serious and devastating infectious disease worldwide. Approximately a quarter of the world…”
    Get full text
    Journal Article
  20. 20